How is the MBX Biosciences Inc. today?

The MBX Biosciences Inc. today is trading in the green, up by 1.02% at 13.80.

How has MBX Biosciences Inc. performed historically?

The MBX Biosciences Inc. is currently trading up 1.02% on an intraday basis in the past week the index rose 9.52%. The index has been up 36.09% in the past quarter and fell None% in the past year. You can view this in the overview section.

What is MBX Biosciences Inc. Annual Net Profit?

MBX Biosciences Inc. Annual Net Profit fell 90.16% in the last year to $61.92 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is MBX Biosciences Inc. Price to Earning Ratio?

MBX Biosciences Inc. Price to Earning Ratio is -6.28, which is negative.

What is MBX Biosciences Inc. Stock Price?

MBX Biosciences Inc. Stock Price rose 9.52% outperformed its sector by 6.62% in the past week.

What is MBX Biosciences Inc. Quarterly Net profit?

MBX Biosciences Inc. Quarterly Net profit fell 93.56% YoY to $23.88 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is MBX Biosciences Inc. Debt to Equity Ratio?

MBX Biosciences Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is MBX Biosciences Inc. Return on Equity(ROE)?

MBX Biosciences Inc. Return on Equity(ROE) for the last financial year was -66.95%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is MBX Biosciences Inc. Mutual Fund Holding?

MBX Biosciences Inc. Mutual Fund Holding decreased by 2.04% in the last quarter to 11.17.

What is MBX Biosciences Inc. Institutional Holding?

MBX Biosciences Inc. Institutional Holding increased by 8.75% in the last quarter to 89.36.

MBX Biosciences Inc. XNAS: MBX

MBX Biosciences Inc. Live Share Price Today, Share Analysis and Chart

Name: MBX Biosciences Inc.: Is Infosys Ltd. worth buying?
Item: MBX Biosciences Inc.
Rating: 1.27466675
Author: Trendlyne DVM scores

about

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision End...

13.80 0.14 (1.02%)

49.82% Fall from 52W High

71,019 XNAS Volume

XNAS 04 Jun, 2025 11:47 AM (EDT)

Board Meeting

The next board meeting for MBX Biosciences Inc. is on 09 Jun 2025 for the purpose of https://investors.mbxbio.com/events/event-details/goldman-sachs-46th-annual-global-healthcare-conference See details

Not Eligible

Expensive Valuation

8.2 / 100

Technically Neutral

42.8 / 100

No estimates available

MBX Biosciences Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

MBX Biosciences Inc. Live Share Price Today, Share Analysis and Chart

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision End...

49.82% Fall from 52W High

SWOT Analysis

MBX Biosciences Inc. Live Price Chart

MBX Biosciences Inc. FAQ

How is MBX Biosciences Inc. today?

MBX Biosciences Inc. today is trading in the green, and is up by 1.02% at 13.80.

How has MBX Biosciences Inc. performed historically?

MBX Biosciences Inc. is currently trading up 1.02% on an intraday basis. In the past week the stock rose 9.52%. stock has been up 36.09% in the past quarter and fell None% in the past year. You can view this in the overview section.